Epigenetics, development, and cancer

Zebrafish make their ARK

Raksha Mudbhary, Kirsten Sadler Edepli

    Research output: Contribution to journalReview article

    Abstract

    Zebrafish embryos are an exceptional system for studying vertebrate development. Historically, studies using zebrafish to uncover key players in developmentally regulated gene expression have entailed detailed analysis of transcription factors. It is now apparent that epigenetic modifications of both DNA and histone tails are equally important in the regulation of gene expression during development. As such, blocking the function of key epigenetic modifiers impairs development, albeit with surprising tissue specificity. For instance, DNA methylation is an important epigenetic mark that is depleted in embryos lacking dnmt1 and uhrf1. These embryos display developmental defects in the eye, liver, pancreas, and larval lethality. Interestingly, human tumors derived from these same organs have aberrant changes in DNA methylation and altered expression of genes that are thought to contribute to formation of these cancers. These observations have provided a mechanistic basis for treating cancer with drugs that block the enzymes that facilitate DNA and histone modifications. Thus, it is important to understand the consequences of targeting these factors in a whole animal. We review the use of zebrafish for probing the genetic, cellular, and physiological response to alterations in the epigenome and highlight exciting data illustrating that epigenetic studies using zebrafish can inform and impact cancer biology.

    Original languageEnglish (US)
    Pages (from-to)194-203
    Number of pages10
    JournalBirth Defects Research Part C - Embryo Today: Reviews
    Volume93
    Issue number2
    DOIs
    StatePublished - Jun 1 2011

    Fingerprint

    Zebrafish
    Epigenomics
    Embryonic Structures
    DNA Methylation
    Neoplasms
    Histone Code
    Gene Expression
    Organ Specificity
    DNA
    Gene Expression Regulation
    Histones
    Vertebrates
    Tail
    Pancreas
    Transcription Factors
    Liver
    Enzymes
    Pharmaceutical Preparations

    Keywords

    • Development
    • DNA methylation
    • DNMT1
    • Histone acetylation
    • Histone methylation
    • UHRF1

    ASJC Scopus subject areas

    • Embryology
    • Developmental Biology

    Cite this

    Epigenetics, development, and cancer : Zebrafish make their ARK. / Mudbhary, Raksha; Sadler Edepli, Kirsten.

    In: Birth Defects Research Part C - Embryo Today: Reviews, Vol. 93, No. 2, 01.06.2011, p. 194-203.

    Research output: Contribution to journalReview article

    Mudbhary, Raksha ; Sadler Edepli, Kirsten. / Epigenetics, development, and cancer : Zebrafish make their ARK. In: Birth Defects Research Part C - Embryo Today: Reviews. 2011 ; Vol. 93, No. 2. pp. 194-203.
    @article{99ddf841d97a4d848e0816a71fa6ba09,
    title = "Epigenetics, development, and cancer: Zebrafish make their ARK",
    abstract = "Zebrafish embryos are an exceptional system for studying vertebrate development. Historically, studies using zebrafish to uncover key players in developmentally regulated gene expression have entailed detailed analysis of transcription factors. It is now apparent that epigenetic modifications of both DNA and histone tails are equally important in the regulation of gene expression during development. As such, blocking the function of key epigenetic modifiers impairs development, albeit with surprising tissue specificity. For instance, DNA methylation is an important epigenetic mark that is depleted in embryos lacking dnmt1 and uhrf1. These embryos display developmental defects in the eye, liver, pancreas, and larval lethality. Interestingly, human tumors derived from these same organs have aberrant changes in DNA methylation and altered expression of genes that are thought to contribute to formation of these cancers. These observations have provided a mechanistic basis for treating cancer with drugs that block the enzymes that facilitate DNA and histone modifications. Thus, it is important to understand the consequences of targeting these factors in a whole animal. We review the use of zebrafish for probing the genetic, cellular, and physiological response to alterations in the epigenome and highlight exciting data illustrating that epigenetic studies using zebrafish can inform and impact cancer biology.",
    keywords = "Development, DNA methylation, DNMT1, Histone acetylation, Histone methylation, UHRF1",
    author = "Raksha Mudbhary and {Sadler Edepli}, Kirsten",
    year = "2011",
    month = "6",
    day = "1",
    doi = "10.1002/bdrc.20207",
    language = "English (US)",
    volume = "93",
    pages = "194--203",
    journal = "Birth Defects Research Part C - Embryo Today: Reviews",
    issn = "1542-975X",
    publisher = "Wiley-Liss Inc.",
    number = "2",

    }

    TY - JOUR

    T1 - Epigenetics, development, and cancer

    T2 - Zebrafish make their ARK

    AU - Mudbhary, Raksha

    AU - Sadler Edepli, Kirsten

    PY - 2011/6/1

    Y1 - 2011/6/1

    N2 - Zebrafish embryos are an exceptional system for studying vertebrate development. Historically, studies using zebrafish to uncover key players in developmentally regulated gene expression have entailed detailed analysis of transcription factors. It is now apparent that epigenetic modifications of both DNA and histone tails are equally important in the regulation of gene expression during development. As such, blocking the function of key epigenetic modifiers impairs development, albeit with surprising tissue specificity. For instance, DNA methylation is an important epigenetic mark that is depleted in embryos lacking dnmt1 and uhrf1. These embryos display developmental defects in the eye, liver, pancreas, and larval lethality. Interestingly, human tumors derived from these same organs have aberrant changes in DNA methylation and altered expression of genes that are thought to contribute to formation of these cancers. These observations have provided a mechanistic basis for treating cancer with drugs that block the enzymes that facilitate DNA and histone modifications. Thus, it is important to understand the consequences of targeting these factors in a whole animal. We review the use of zebrafish for probing the genetic, cellular, and physiological response to alterations in the epigenome and highlight exciting data illustrating that epigenetic studies using zebrafish can inform and impact cancer biology.

    AB - Zebrafish embryos are an exceptional system for studying vertebrate development. Historically, studies using zebrafish to uncover key players in developmentally regulated gene expression have entailed detailed analysis of transcription factors. It is now apparent that epigenetic modifications of both DNA and histone tails are equally important in the regulation of gene expression during development. As such, blocking the function of key epigenetic modifiers impairs development, albeit with surprising tissue specificity. For instance, DNA methylation is an important epigenetic mark that is depleted in embryos lacking dnmt1 and uhrf1. These embryos display developmental defects in the eye, liver, pancreas, and larval lethality. Interestingly, human tumors derived from these same organs have aberrant changes in DNA methylation and altered expression of genes that are thought to contribute to formation of these cancers. These observations have provided a mechanistic basis for treating cancer with drugs that block the enzymes that facilitate DNA and histone modifications. Thus, it is important to understand the consequences of targeting these factors in a whole animal. We review the use of zebrafish for probing the genetic, cellular, and physiological response to alterations in the epigenome and highlight exciting data illustrating that epigenetic studies using zebrafish can inform and impact cancer biology.

    KW - Development

    KW - DNA methylation

    KW - DNMT1

    KW - Histone acetylation

    KW - Histone methylation

    KW - UHRF1

    UR - http://www.scopus.com/inward/record.url?scp=79958821173&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=79958821173&partnerID=8YFLogxK

    U2 - 10.1002/bdrc.20207

    DO - 10.1002/bdrc.20207

    M3 - Review article

    VL - 93

    SP - 194

    EP - 203

    JO - Birth Defects Research Part C - Embryo Today: Reviews

    JF - Birth Defects Research Part C - Embryo Today: Reviews

    SN - 1542-975X

    IS - 2

    ER -